Skip to content

Aino ECG Ambulatory Study

Detection of Cardiac Arrhythmias With Wrist-worn Combined Optical and ECG Based Heart Rate Monitor During Normal Daily Living

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05008601
Enrollment
31
Registered
2021-08-17
Start date
2021-04-01
Completion date
2021-08-01
Last updated
2021-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias, Cardiac, Atrial Fibrillation and Flutter

Brief summary

The study includes collection of data from patients referred to a therapeutic evaluation in Tays Sydänkeskus Oy (Heart Center Co, Tampere University Hospital) or another unit of Sydänkeskus (hereafter the Heart Hospital) due to suspected cardiac arrhythmia. Data collection takes place outside the hospital in normal daily conditions. The monitoring is started during the outpatient visit at Heart hospital polyclinic or when leaving home from cardiac ward and it continues for 2 days. Reference information about the occurrence of arrhythmia episodes and the reference ECG data are obtained from simultaneously worn Holter device. During the two days the study device and the reference device are worn continuously. Wearing the devices does not affect the daily routines of the participant except there is no possibility to take a shower. The arrhythmia episodes are labelled in post-hoc signal analysis and annotations visually confirmed by a cardiologist. The participants are instructed to take ECG recordings with the wrist device every time the device gives a notification and also whenever the participant feels arrhythmia symptoms. There will be at least four intermittent ECG records taken on each day.

Interventions

DEVICEWrist-word optical heart rate and ECG measurement device

Aino ECG: wrist-word optical heart rate and ECG measurement device

Sponsors

TAYS Sydänkeskus Oy
CollaboratorUNKNOWN
Atostek Oy
CollaboratorUNKNOWN
PulseOn Oy
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Age: ≥ 18 years * Suspected or earlier diagnosed episodic cardiac arrhythmia, for example atrial fibrillation or atrial flutter * Ability to give informed consent * Volunteering for the study

Exclusion criteria

* Implanted permanent pacemaker * Inability to give informed consent e.g. due to mental confusion * Denial

Design outcomes

Primary

MeasureTime frame
Verification that the atrial fibrillation detection sensitivity satisfies the design input requirements defined for the Aino ECG device6 months
Verification that the data accuracy (accuracy of optically measured inter-beat-intervals) satisfies the design input requirement defined for the Aino ECG device.6 months
Verification that the quality of the ECG signal measured with Aino ECG satisfies the design input requirement defined for the Aino ECG device.6 months

Secondary

MeasureTime frameDescription
Showing that the quality of the measured PPG signal is similar enough compared with the one measured with the earlier prototype6 months
To obtain feedback regarding the usability of the Aino ECG wrist device6 monthsThe feedback is obtained with feedback form filled by the study participants. The form includes questions regarding: overall impression on the study device, easiness of noticing and interpret the notifications of the device, comfortability of using the device, easiness of adjusting the tightness of the wrist band, and operation of the intermittent ECG measurements.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026